Results 11 to 20 of about 4,566 (189)

Codon deoptimization of multispecific biologics reduces mispairing during transient mammalian protein expression [PDF]

open access: yesFrontiers in Bioengineering and Biotechnology
IntroductionCodon optimization is utilized in biologics design to maximize protein expression. Selecting the host organism’s most frequently used codons for each amino acid can significantly enhance recombinant protein expression yields.
Timothy Z. Chang   +10 more
doaj   +2 more sources

Toward Drug-Like Multispecific Antibodies by Design [PDF]

open access: yesInternational Journal of Molecular Sciences, 2020
The success of antibody therapeutics is strongly influenced by their multifunctional nature that couples antigen recognition mediated by their variable regions with effector functions and half-life extension mediated by a subset of their constant regions.
Sawant, Manali S.   +3 more
openaire   +3 more sources

Antineutrophil Cytoplasmic Autoantibodies Specific to Bactericidal/Permeability-Increasing Protein: A Cross-Road Between Prolonged Gram-Negative Bacterial Infections and Ulcerative Colitis/Primary Sclerosing Cholangitis [PDF]

open access: yesDiagnostics
Background/Objectives: Binding of bactericidal/permeability-increasing (BPI) protein to Gram-negative (GN) bacteria plays a major role in bacterial elimination.
Dragana Jovanovic   +7 more
doaj   +2 more sources

Affinity- and specificity-enhancing mutations are frequent in multispecific interactions between TIMP2 and MMPs.

open access: yesPLoS ONE, 2014
Multispecific proteins play a major role in controlling various functions such as signaling, regulation of transcription/translation, and immune response. Hence, a thorough understanding of the atomic-level principles governing multispecific interactions
Oz Sharabi   +5 more
doaj   +2 more sources

Immunotherapy 3.0: Breakthroughs Steering the Next Generation of Cancer Control. [PDF]

open access: yesCancer Rep (Hoboken)
ABSTRACT Background Hematologic disorders, including sickle cell disease, anemias, hemoglobinopathies, leukemias, lymphomas, and bleeding disorders, constitute a substantial and growing burden of morbidity and mortality across Africa. Structural health system constraints—limited diagnostic capacity, shortages of trained hematology specialists ...
Obeagu EI.
europepmc   +2 more sources

Next generation Fc scaffold for multispecific antibodies [PDF]

open access: yesiScience, 2021
Summary: Bispecific antibodies (Bispecifics) demonstrate exceptional clinical potential to address some of the most complex diseases. However, Bispecific production in a single cell often requires the correct pairing of multiple polypeptide chains for ...
Bram Estes   +11 more
doaj   +3 more sources

“Stapling” scFv for multispecific biotherapeutics of superior properties

open access: yesmAbs, 2023
Single-chain fragment variable (scFv) domains play an important role in antibody-based therapeutic modalities, such as bispecifics, multispecifics and chimeric antigen receptor T cells or natural killer cells.
Lauren E. Boucher   +29 more
doaj   +3 more sources

Tradeoff between stability and multispecificity in the design of promiscuous proteins. [PDF]

open access: yesPLoS Computational Biology, 2009
Natural proteins often partake in several highly specific protein-protein interactions. They are thus subject to multiple opposing forces during evolutionary selection.
Menachem Fromer, Julia M Shifman
doaj   +4 more sources

Broadly Protective Antibody-Like Vaccines Against Highly Pathogenic Coronaviruses. [PDF]

open access: yesJ Med Virol
ABSTRACT SARS‐CoV‐2 and MERS‐CoV are highly pathogenic and contagious coronaviruses. Despite intensive vaccination, SARS‐CoV‐2 continues to spread, and no FDA‐approved vaccines exist for MERS‐CoV; thus, more effective and safer vaccine options are needed. The receptor‐binding domain (RBD) of coronaviruses is a primary target of neutralizing antibodies (
Helal A   +20 more
europepmc   +2 more sources

DNA‐Mediated Assembly of Multispecific Antibodies for T Cell Engaging and Tumor Killing

open access: yesAdvanced Science, 2020
Targeting T‐cells against cancer cells is a direct means of treating cancer, and has already shown great responses in clinical treatment of B‐cell malignancies.
Liqiang Pan, James J Chou
exaly   +2 more sources

Home - About - Disclaimer - Privacy